These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 19054174

  • 1. History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram.
    Kawakami S, Koga F, Fujii Y, Saito K, Yamamoto S, Tatokoro M, Yonese J, Kageyama Y, Fukui I, Kihara K.
    Int J Urol; 2008 Dec; 15(12):1055-60. PubMed ID: 19054174
    [Abstract] [Full Text] [Related]

  • 2. Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL.
    Kawamura K, Suzuki H, Kamiya N, Imamoto T, Yano M, Miura J, Shimbo M, Suzuki N, Nakatsu H, Ichikawa T.
    Int J Urol; 2008 Jul; 15(7):598-603. PubMed ID: 18462353
    [Abstract] [Full Text] [Related]

  • 3. Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
    Kawakami S, Numao N, Okubo Y, Koga F, Yamamoto S, Saito K, Fujii Y, Yonese J, Masuda H, Kihara K, Fukui I.
    Eur Urol; 2008 Sep; 54(3):601-11. PubMed ID: 18207312
    [Abstract] [Full Text] [Related]

  • 4. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10 ng/mL.
    Garzotto M, Hudson RG, Peters L, Hsieh YC, Barrera E, Mori M, Beer TM, Klein T.
    Cancer; 2003 Oct 01; 98(7):1417-22. PubMed ID: 14508828
    [Abstract] [Full Text] [Related]

  • 5. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients.
    Suzuki H, Komiya A, Kamiya N, Imamoto T, Kawamura K, Miura J, Suzuki N, Nakatsu H, Hata A, Ichikawa T.
    Urology; 2006 Jan 01; 67(1):131-6. PubMed ID: 16413348
    [Abstract] [Full Text] [Related]

  • 6. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer.
    Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Loblaw A, Pond GR, Emami M, Sugar L, Sweet J, Narod SA.
    Can J Urol; 2006 Apr 01; 13 Suppl 2():2-10. PubMed ID: 16672122
    [Abstract] [Full Text] [Related]

  • 7. Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.
    Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA.
    J Clin Oncol; 2007 Jul 20; 25(21):3076-81. PubMed ID: 17634486
    [Abstract] [Full Text] [Related]

  • 8. Assessing individual risk for prostate cancer.
    Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW.
    J Clin Oncol; 2007 Aug 20; 25(24):3582-8. PubMed ID: 17704405
    [Abstract] [Full Text] [Related]

  • 9. Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.
    Eggener SE, Roehl KA, Catalona WJ.
    J Urol; 2005 Aug 20; 174(2):500-4. PubMed ID: 16006880
    [Abstract] [Full Text] [Related]

  • 10. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A, Chun FK, Salonia A, Gallina A, Farina E, Da Pozzo LF, Rigatti P, Montorsi F, Karakiewicz PI.
    BJU Int; 2006 Oct 20; 98(4):788-93. PubMed ID: 16796698
    [Abstract] [Full Text] [Related]

  • 11. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H, Wang X, Ochiai A, Trpkov K, Yilmaz A, Donnelly JB, Davis JW, Troncoso P, Babaian RJ.
    Cancer; 2007 Dec 01; 110(11):2441-7. PubMed ID: 17932909
    [Abstract] [Full Text] [Related]

  • 12. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.
    Bozeman CB, Carver BS, Caldito G, Venable DD, Eastham JA.
    Urology; 2005 Oct 01; 66(4):803-7. PubMed ID: 16230142
    [Abstract] [Full Text] [Related]

  • 13. The value of digital rectal examination as a predictor of prostate cancer diagnosis among United States Veterans referred for prostate biopsy.
    Issa MM, Zasada W, Ward K, Hall JA, Petros JA, Ritenour CW, Goodman M, Kleinbaum D, Mandel J, Marshall FF.
    Cancer Detect Prev; 2006 Oct 01; 30(3):269-75. PubMed ID: 16844319
    [Abstract] [Full Text] [Related]

  • 14. Development and external validation of an extended 10-core biopsy nomogram.
    Chun FK, Briganti A, Graefen M, Montorsi F, Porter C, Scattoni V, Gallina A, Walz J, Haese A, Steuber T, Erbersdobler A, Schlomm T, Ahyai SA, Currlin E, Valiquette L, Heinzer H, Rigatti P, Huland H, Karakiewicz PI.
    Eur Urol; 2007 Aug 01; 52(2):436-44. PubMed ID: 17010505
    [Abstract] [Full Text] [Related]

  • 15. Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy.
    Nam RK, Toi A, Trachtenberg J, Klotz LH, Jewett MA, Emami M, Sugar L, Sweet J, Pond GR, Narod SA.
    J Urol; 2006 Feb 01; 175(2):489-94. PubMed ID: 16406978
    [Abstract] [Full Text] [Related]

  • 16. Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.
    Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, Thompson IM, Leach RJ, Parekh DJ.
    Urology; 2007 Oct 01; 70(4):748-52. PubMed ID: 17991549
    [Abstract] [Full Text] [Related]

  • 17. Models to predict positive prostate biopsies using the Tyrol screening study.
    Sooriakumaran P, John M, Christos P, Bektic J, Bartsch G, Leung R, Herman M, Scherr D, Tewari A.
    Urology; 2011 Oct 01; 78(4):924-9. PubMed ID: 21840579
    [Abstract] [Full Text] [Related]

  • 18. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
    Zaytoun OM, Kattan MW, Moussa AS, Li J, Yu C, Jones JS.
    Urology; 2011 Aug 01; 78(2):392-8. PubMed ID: 21705045
    [Abstract] [Full Text] [Related]

  • 19. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
    Yanke BV, Gonen M, Scardino PT, Kattan MW.
    J Urol; 2005 Feb 01; 173(2):421-4. PubMed ID: 15643192
    [Abstract] [Full Text] [Related]

  • 20. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M, Bahilo P, Arlandis S, Santamaría Navarro C, Pontones Moreno JL, Jiménez-Cruz F.
    Actas Urol Esp; 2010 Jan 01; 34(1):35-42. PubMed ID: 20223131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.